Anticancer agents incorporating the N‐acylhydrazone scaffold: Progress from 2017 to present.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200548
- By:
- Publication type:
- Article
Works matching IS 03656233 AND DT 2023 AND VI 356 AND IP 5
Results: 14
1
2
Pyrazole scaffold‐based derivatives: A glimpse of α‐glucosidase inhibitory activity, SAR, and route of synthesis.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200421
- By:
- Publication type:
- Article
3
Synthesis and biological evaluation of benzamide‐chalcone hybrids as potential c‐Met kinase and COX‐2 inhibitors.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200405
- By:
- Publication type:
- Article
4
Editorial Board: Arch Pharm (5/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202370010
- Publication type:
- Article
5
New benzimidazole‐oxadiazole derivatives: Synthesis, α‐glucosidase, α‐amylase activity, and molecular modeling studies as potential antidiabetic agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200663
- By:
- Publication type:
- Article
6
Cover Picture: Arch Pharm (5/2023).
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202370009
- Publication type:
- Article
7
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200655
- By:
- Publication type:
- Article
8
Design, synthesis, molecular docking, and biological evaluation of coumarin‐thymidine analogs as potent anti‐TB agents.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200633
- By:
- Publication type:
- Article
9
Development of a multigram synthesis of the bradykinin receptor 2 agonist FR‐190997 and analogs thereof.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200610
- By:
- Publication type:
- Article
10
A graphite furnace‐atomic absorption spectrometry‐based rubidium efflux assay for screening activators of the K<sub>v</sub>7.2/3 channel.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200585
- By:
- Publication type:
- Article
11
SC‐560 and mofezolac isosteres as new potent COX‐1 selective inhibitors with antiplatelet effect.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200549
- By:
- Publication type:
- Article
12
Blood pH and COVID‐19.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200558
- By:
- Publication type:
- Article
13
Exploration of ethylene glycol linked nitrofurantoin derivatives against Leishmania: Synthesis and in vitro activity.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200529
- By:
- Publication type:
- Article
14
Triazolo‐linked benzimidazoles as tubulin polymerization inhibitors and DNA intercalators: Design, synthesis, cytotoxicity, and docking studies.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 5, p. 1, doi. 10.1002/ardp.202200449
- By:
- Publication type:
- Article